As of January 22, 2025, Sanofi (SNY) has a market cap of $129.28 billion USD. According to our data, Sanofi is ranked No.126 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $129.28 B |
6.91%
|
Dec 31, 2024 | $120.92 B |
1.09%
|
Dec 29, 2023 | $119.61 B |
6.55%
|
Dec 30, 2022 | $112.26 B |
0.47%
|
Dec 31, 2021 | $111.74 B |
7.00%
|
Dec 31, 2020 | $104.43 B |
0.38%
|
Dec 31, 2019 | $104.03 B |
20.47%
|
Dec 31, 2018 | $86.35 B |
6.06%
|
Dec 29, 2017 | $81.42 B |
9.82%
|
Dec 30, 2016 | $74.14 B |
-1.19%
|
Dec 31, 2015 | $75.04 B |
-3.37%
|
Dec 31, 2014 | $77.66 B |
-11.86%
|
Dec 31, 2013 | $88.10 B |
17.11%
|
Dec 31, 2012 | $75.23 B |
35.98%
|
Dec 30, 2011 | $55.32 B |
18.86%
|
Dec 31, 2010 | $46.55 B |
-13.46%
|
Dec 31, 2009 | $53.79 B |
28.72%
|
Dec 31, 2008 | $41.79 B |
-26.49%
|
Dec 31, 2007 | $56.84 B |
1.02%
|
Dec 29, 2006 | $56.27 B |
7.24%
|
Dec 30, 2005 | $52.47 B |
11.59%
|
Dec 31, 2004 | $47.02 B |
8.24%
|
Dec 31, 2003 | $43.44 B |
26.09%
|
Dec 31, 2002 | $34.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$149.23 B |
0.006 M
|
USA
|
Johnson & Johnson
JNJ
|
$344.66 B |
0.016 M
|
USA
|
Merck
MRK
|
$244.82 B |
-0.007 M
|
USA
|
Novartis
NVS
|
$197.90 B |
0.005 M
|
Switzerland
|
GlaxoSmithKline
GSK
|
$68.43 B |
-0.001 M
|
UK
|
AstraZeneca
AZN
|
$211.48 B |
0.004 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$114.88 B |
-0.811 B
|
USA
|
Eli Lilly
LLY
|
$679.60 B |
0.019 M
|
USA
|
AbbVie
ABBV
|
$297.92 B |
0.013 M
|
USA
|
Amgen
AMGN
|
$146.94 B |
0.008 M
|
USA
|
Takeda Pharmaceutical
TAK
|
$41.29 B |
-0.238 B
|
Japan
|
Gilead Sciences
GILD
|
$115.25 B |
-0.604 B
|
USA
|
Biogen
BIIB
|
$20.75 B |
0.203 B
|
USA
|
Market Cap | = | SNY Stock Price | * | SNY Shares Outstanding |
= | $51.56 | * | 2.51 B | |
= | $129.28 B |